Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorFirst Affiliated Hospital Xi'an Jiaotong University

About this trial

Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Simultaneous cortico-spinal magnetic resonance imaging, Serum

Treatment groups

600 Participants
are divided into 3 treatment groups

Sponsors and collaborators

First Affiliated Hospital Xi'an Jiaotong University

Lead sponsor

Nuclear 215 Hospital of Shaanxi Province

Collaborator

Yanan Traditional Chinese Medicine Hospital

Collaborator

Shangluo Central Hospital

Collaborator

Xian QinHuang Hospital

Collaborator

Yulin No.2 Hospital

Collaborator

Hanzhong Central Hospital

Collaborator

Ankang Central Hospital

Collaborator

Baoji High-tech Hospital

Collaborator